No menu items!

Brazil’s diagnostic giant DASA buys oncology specialist GEM Assistência Médica for US$150 million

RIO DE JANEIRO, BRAZIL - DASA - Diagnósticos da América SA, the market leader in diagnostic medicine in Brazil and Latin America, announced that its Board of Directors approved the purchase of partner and control companies of GEM Assistência Médica through its subsidiary Ímpar Serviços Hospitalares for an amount of R$750 million (US$150 million).

Ímpar agreed to buy 100% of Paquetá Participações and AMO Participações. The two together own 99.69% of GEM's total capital and 100% of the company's voting capital.

DASA also stated that the total amount is still . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content